Navigation Links
Israeli Minister of Industry and Trade to address European R&D leaders in Tel Aviv

October 20, 2010 TEL AVIV, Israel - European business leaders and high-level representatives from the EUREKA Network, Europe's leading platform for R&D-performing entrepreneurs and industries, will gather in Tel Aviv during the final week of October to take part in the first event in Israel under the Israeli EUREKA Chairmanship. The year-long chairmanship puts Israel at the reigns of the EUREKA Network and will provide European industries with unprecedented exposure to Israeli innovation, technology, its wealth of knowledge and its entrepreneurship.

The first event being held in Israel during the Chairmanship year (July 2010 June 2011) will bring together industry leaders, scientists, European Commission representatives, and EUREKA's High Level Group Representatives and National Project Coordinators from 40 countries the leading decision makers and project generators of EUREKA. These government representatives promote industry, technology, R&D, and international cooperation. They will be joined by a special delegation of 40 companies from South Korea, the first country outside of Europe granted "Associated" status by EUREKA. The meeting will be hosted by Israel's Minister of Industry and Trade, Mr. Benyamin Ben-Eliezer, who will be addressing attendees along with the Israeli Chief Scientist Dr. Eli Opper, Chairman of the EUREKA High Level Group, who will formally announce the planned EUREKA program for the coming year.

Also being endorsed at the meetings is the EUREKA "Clean-Tech Initiative", a campaign that will be launched in February aimed at encouraging project proposals focused on R&D cooperation in the clean-tech sector renewable energy, environmental and water technologies.

On a yearly basis, EUREKA supports more than 300 collaborative projects in a variety of industries, totaling over 1.5 billion Euros. These industrial projects match up partners from two or more member countries including small and medium-sized enterprises (SMEs), large industry, and research institutes. Projects can be launched in virtually all industry fields and technological areas IT, manufacturing, water technologies, communications, biotechnology and energy, among others. EUREKA initiatives look to meet challenges such as climate change, energy security, and limited water resources.

Israel's chairmanship of EUREKA is being led by the Chief Scientist Dr. Eli Opper and the Israeli Ministry of Industry and Trade, through MATIMOP the Israeli Industry Center for Research and Development, which is the executive agency of the Chief Scientist's office. The Israeli leadership of EUREKA will provide an opportunity to showcase Israel's culture of innovation and entrepreneurship. Indeed, at the ripe of age of 62, Israel has been coined the "start-up nation" of the world. With over 3,800 technology-based start-up companies, innovation has become a key factor in the country's economic stability and success assets reflected in its participation in EUREKA projects. Israel is actually one of EUREKA's most active participants; of EUREKA's 40 member countries, Israeli companies have partnered in more than 10% of all EUREKA projects. The Chairmanship provides enormous opportunities for Israeli and European companies and highlights Israel's unique contributions to European innovation and R&D.


Contact: Adam Murray

Related biology news :

1. Single gene dramatically boosts yield, sweetness in tomato hybrids, CSHL-Israeli study finds
2. Why Israeli rodents are more cautious than Jordanian ones
3. German Research Minister Schavan: Rapid knowledge transfer can safe lives
4. Reportlinker Adds Global Biometrics Industry
5. Can naturally raised beef find its place in the industry?
6. Industry to Demonstrate Off-the-Shelf Integrated Force Protection and Counter-Terrorism Solutions at Northern Virginia Site
7. Growth of biofuel industry hurt by GMO regulations
8. Industry to Demonstrate Off-the-Shelf Integrated Force Protection and Counter-Terrorism Solutions at Northern Virginia Site
9. Deepwater Horizon committee hears from oil industry executives -- Sept. 26 public meeting
10. Invaders could devastate Florida avocado industry
11. Sequencing of cacao genome will help US chocolate industry, subsistence farmers
Post Your Comments:
(Date:11/9/2015)... 2015 ... "Global Law Enforcement Biometrics Market 2015-2019" ... ) has announced the addition ... Market 2015-2019" report to their offering. ... ) has announced the addition of ...
(Date:11/2/2015)... , Nov. 2, 2015  SRI International has ... to provide preclinical development services to the National Cancer ... SRI will provide scientific expertise, modern testing and support ... of preclinical pharmacology and toxicology studies to evaluate potential ... --> The PREVENT Cancer Drug Development Program is ...
(Date:10/29/2015)... , Oct. 29, 2015 Daon, a global ... it has released a new version of its ... North America have already installed ... also includes a FIDO UAF certified server component ... preparing to activate FIDO features. These customers include some ...
Breaking Biology News(10 mins):
(Date:11/30/2015)... Nov. 30, 2015  Northwest Biotherapeutics (NASDAQ: NWBO ... personalized immune therapies for solid tumor cancers, announced today ... independent director, and the Company welcomes Neil Woodford,s ... a recent anonymous internet report on NW Bio.  The ... Linda Powers stated, "We agree with Mr. ...
(Date:11/27/2015)... ... November 27, 2015 , ... Pittcon is pleased to ... presentations offered in symposia, oral sessions, workshops, awards, and posters. The core ... of applications such as, but not limited to, biotechnology, biomedical, drug discovery, environmental, ...
(Date:11/25/2015)... 2015  PharmAthene, Inc. (NYSE MKT: PIP) announced  today ... rights plan (Rights Plan) in an effort to preserve ... under Section 382 of the Internal Revenue Code (Code). ... use of its NOLs could be substantially limited if ... Section 382 of the Code. In general, an ownership ...
(Date:11/25/2015)... QUEBEC CITY , Nov. 25, 2015 /PRNewswire/ ... "Company"), affirms that its business and prospects remain ... , Zoptrex™ (zoptarelin doxorubicin) recently received DSMB ... program to completion following review of the final ... met Phase 2 Primary Endpoint in men with ...
Breaking Biology Technology: